Disseminated human papillomavirus type 11 infection in a patient with pemphigus vulgaris: Confirmed by DNA analysis

Ko, Mei‐Ju; Chu, Chia-Yu

doi:10.1016/j.jaad.2004.04.037

Cited by 16 publications

(8 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are many reports regarding predisposition to infections due to immunosuppressive therapy and the immunocompromised state of pemphigus patients [6, 7]. …”

Section: Introductionmentioning

confidence: 99%

Pemphigus Vulgaris and Infections: A Retrospective Study on 155 Patients

Esmaili

Mortazavi

Noormohammadpour

et al. 2013

Autoimmune Diseases

View full text Add to dashboard Cite

Background. Autoimmune process and immunosuppressive therapy of pemphigus vulgaris would predispose the patients to infections. Aim. We aimed to study the prevalence of infection and pathogenic agents in pemphigus vulgaris patients admitted to dermatology service. Material and methods. This retrospective study was conducted on 155 pemphigus vulgaris patients (68 males, 87 females) admitted to dermatology service between 2009 and 2011. In this study, the diagnosis of pemphigus vulgaris was confirmed by light microscopic and direct immunofluorescence findings. Data were collected through a questionnaire. Results. Of 155 pemphigus vulgaris patients, 33 had infection at admission and 9 acquired nosocomial infection. In addition, 37 cases of oral candidiasis and 15 cases of localized herpes simplex were recorded. Totally, 94 cases of infection were recorded. The occurrence of infection was significantly related to the severity of disease, number of hospital admissions, and presence of diabetes mellitus. The most common pathogenic germs isolated from cultures were Staphylococcus aureus and Escherichia coli. Conclusion. Severity of pemphigus vulgaris and diabetes were directly related with tendency to infections. Staphylococcus aureus and Escherichia coli were the most common pathogenic agents. Due to limitations of retrospective study, a prospective study is recommended.

show abstract

“…There are many reports regarding predisposition to infections due to immunosuppressive therapy and the immunocompromised state of pemphigus patients [6, 7]. …”

Section: Introductionmentioning

confidence: 99%

Pemphigus Vulgaris and Infections: A Retrospective Study on 155 Patients

Esmaili

Mortazavi

Noormohammadpour

et al. 2013

Autoimmune Diseases

View full text Add to dashboard Cite

show abstract

“…HPV infection with high‐risk types has also been linked to laryngeal, penile, and anal carcinoma . Disseminated HPV11 has been reported in a patient with pemphigus, as has an HPV‐related oral carcinoma in a patient with mucous membrane pemphigoid…”

Section: Resultsmentioning

confidence: 99%

“…38 HPV infection with high-risk types has also been linked to laryngeal, penile, and anal carcinoma. 38 Disseminated HPV11 has been reported in a patient with pemphigus, 39 as has an HPV-related oral carcinoma in a patient with mucous membrane pemphigoid. 40 Vaccination is licensed for males and females aged 9-26 years and is preferably given before the onset of sexual activity.…”

Section: Human Papillomavirus Vaccinementioning

confidence: 99%

Literature‐based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses

2015

View full text Add to dashboard Cite

Autoimmune bullous diseases, such as pemphigus, pemphigoid, and dermatitis herpetiformis, are uniquely associated with vulnerability in the mucocutaneous barrier against infection. The management of immunobullous diseases is complex and may at times require immunosuppressive medications. Iatrogenic immunosuppression may increase susceptibility to vaccine-preventable illnesses. Currently, there are no guidelines to assist the clinician treating patients with immunobullous disease regarding the delivery of various vaccinations. The aim of this review is to provide recommendations for immunization in the unique setting of immunobullous disease. Recommendations are based on careful review of the literature in other conditions requiring iatrogenic immunosuppression, as well as the most recent Centers for Disease Control and Prevention guidelines. Immunization with nonlive vaccines appears to be a safe and effective strategy for preventing infection in the particularly susceptible patient with immunobullous disease. Opportunities for live vaccine administration may become available at lower levels of immune suppression or during clinical remission when immunosuppressive regimens can be reduced. Anticipatory vaccination before the initiation of iatrogenic immunosuppression is ideal. Although immunologic response to vaccination may be suboptimal during immunosuppression, nonlive vaccination is strongly recommended for this patient population.

show abstract

“…New warts may form at sites of trauma (Koebner phenomenon), though not so frequently as in cases of plane warts. 492 Extensive verrucae have been reported in immunodeficiency syndromes, including CD4 + T-cell lym-dermal infiltrate, with lichenoid features. 464,489 HPV-57 has been reported to produce multiple, sometimes recalcitrant cutaneous verrucae; 468 it is not uncommon in patients with HIV infection.…”

Section: Verruca Vulgarismentioning

confidence: 99%

Viral diseases

Weedon

2010

Weedon's Skin Pathology

View full text Add to dashboard Cite

Disseminated human papillomavirus type 11 infection in a patient with pemphigus vulgaris: Confirmed by DNA analysis

Cited by 16 publications

References 29 publications

Pemphigus Vulgaris and Infections: A Retrospective Study on 155 Patients

Pemphigus Vulgaris and Infections: A Retrospective Study on 155 Patients

Literature‐based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses

Viral diseases

Contact Info

Product

Resources

About